<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Gem-miR-15a &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/gem-mir-15a/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 27 Oct 2026 01:28:52 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Gem-miR-15a &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Gemcitabine-Fused microRNA Shows Promise Against Chemoresistant Colorectal Cancer in Preclinical Models</title>
		<link>https://bioengineer.org/gemcitabine-fused-microrna-shows-promise-against-chemoresistant-colorectal-cancer-in-preclinical-models/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 27 Oct 2026 01:28:52 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[5-fluorouracil]]></category>
		<category><![CDATA[chemoresistance]]></category>
		<category><![CDATA[CHK1]]></category>
		<category><![CDATA[Colorectal cancer]]></category>
		<category><![CDATA[Gem-miR-15a]]></category>
		<category><![CDATA[Gemcitabine]]></category>
		<category><![CDATA[microRNA therapeutics]]></category>
		<category><![CDATA[miR-15a]]></category>
		<category><![CDATA[oxaliplatin]]></category>
		<category><![CDATA[patient-derived organoids]]></category>
		<category><![CDATA[preclinical models]]></category>
		<category><![CDATA[WEE1]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=460107</guid>

					<description><![CDATA[A gemcitabine-modified tumor-suppressor microRNA called Gem-miR-15a overcame 5-FU and oxaliplatin resistance in preclinical colorectal cancer models with low-nanomolar potency and no observable toxicity.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">460107</post-id>	</item>
	</channel>
</rss>
